Literature DB >> 7615838

Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes.

A Yao1, T Takahashi, T Aoyagi, K Kinugawa, O Kohmoto, S Sugiura, T Serizawa.   

Abstract

To investigate how cardiac myocytes recover from a brief period of ischemia, we used a metabolic inhibition (MI) model, one of the in vitro ischemic models, of chick embryo ventricular myocytes, and examined the induction of immediate-early (IE) genes mRNAs and the activity of mitogen-activated protein (MAP) kinase. We performed Northern blot analysis to study the expression of c-jun, c-fos, and c-myc mRNAs during MI using 1 mM NaCN and 20 mM 2-deoxy-d-glucose, and also during the recovery from MI of 30 min. The c-fos mRNA was induced transiently at 30 and 60 min during the recovery. The expression of c-jun mRNA was significantly augmented at 30, 60, 90, and 120 min during the recovery (3.0-, 4.7-, 2.4-, and 1.9-fold induction, respectively) and so did the expression of c-myc mRNA (1.4-, 1.7-, 1.8-, and 2.0-fold induction, respectively). In contrast, the levels of these mRNAs remained unchanged during MI. The electrophoretic mobility shift assay revealed that AP-1 DNA binding activity markedly increased at 120 min during the recovery. When the cells were pretreated with protein kinase C (PKC) inhibitors, 100 microM H-7 or 1 microM staurosporine, the induction of c-jun mRNA at 60 min during the recovery was markedly suppressed (95 or 82% reduction, respectively). The c-jun induction was partially inhibited when the cells were treated with 2 mM EGTA during MI and the recovery (42% reduction). MAP kinase activity quantified with in-gel kinase assay was unchanged during MI, but significantly increased at 5, 10, and 15 min during the recovery (3.0-, 4.1-, and 3.4-fold increase, respectively). S6 kinase activity was also augmented significantly at 15 min during the recovery. Thus, these data suggest that IE genes as well as MAP kinase may play roles in the recovery process of cardiac myocytes from MI, and that the augmentation of c-jun expression needs the activation of PKC and to some extent, [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615838      PMCID: PMC185174          DOI: 10.1172/JCI118081

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells.

Authors:  T J Childs; M H Watson; J S Sanghera; D L Campbell; S L Pelech; A S Mak
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain.

Authors:  R Marais; J Wynne; R Treisman
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

4.  ATP depletion causes a reversible decrease in Na+ pump density in cultured ventricular myocytes.

Authors:  H Ikenouchi; L Zhao; M McMillan; E M Hammond; W H Barry
Journal:  Am J Physiol       Date:  1993-04

5.  Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes.

Authors:  T Yamazaki; K Tobe; E Hoh; K Maemura; T Kaida; I Komuro; H Tamemoto; T Kadowaki; R Nagai; Y Yazaki
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

Review 6.  Ventricular remodeling after myocardial infarction. Experimental and clinical studies.

Authors:  G Ertl; P Gaudron; K Hu
Journal:  Basic Res Cardiol       Date:  1993       Impact factor: 17.165

7.  Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes.

Authors:  K A Webster; D J Discher; N H Bishopric
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

8.  Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.

Authors:  N H Bishopric; V Jayasena; K A Webster
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

9.  Regulation of a major microtubule-associated protein by MPF and MAP kinase.

Authors:  N Shiina; T Moriguchi; K Ohta; Y Gotoh; E Nishida
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism.

Authors:  J Sadoshima; S Izumo
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  5 in total

1.  Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes.

Authors:  A Clerk; P H Sugden
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Role of protein kinase C and 72 kDa heat shock protein in ischemic tolerance following heat stress in the rat heart.

Authors:  R C Kukreja; Y Z Qian; S Okubo; E E Flaherty
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion.

Authors:  Y Mizukami; K i Yoshida
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction.

Authors:  Y Okamoto; A Chaves; J Chen; R Kelley; K Jones; H G Weed; K L Gardner; L Gangi; M Yamaguchi; W Klomkleaw; T Nakayama; R L Hamlin; C Carnes; R Altschuld; J Bauer; T Hai
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.